Certior Financial Group LLC acquired a new stake in shares of Relx Plc (NYSE:RELX - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 8,593 shares of the technology company's stock, valued at approximately $390,000.
Other hedge funds also recently made changes to their positions in the company. Cerity Partners LLC raised its holdings in shares of Relx by 0.5% during the 4th quarter. Cerity Partners LLC now owns 108,074 shares of the technology company's stock valued at $4,989,000 after buying an additional 510 shares in the last quarter. Quadrant Capital Group LLC grew its position in Relx by 3.5% during the fourth quarter. Quadrant Capital Group LLC now owns 23,021 shares of the technology company's stock valued at $1,046,000 after acquiring an additional 773 shares during the last quarter. Russell Investments Group Ltd. raised its stake in shares of Relx by 38.0% during the fourth quarter. Russell Investments Group Ltd. now owns 18,066 shares of the technology company's stock worth $821,000 after acquiring an additional 4,976 shares in the last quarter. Hemenway Trust Co LLC lifted its holdings in shares of Relx by 48.2% in the 4th quarter. Hemenway Trust Co LLC now owns 37,260 shares of the technology company's stock worth $1,692,000 after acquiring an additional 12,115 shares during the last quarter. Finally, Envestnet Asset Management Inc. boosted its stake in shares of Relx by 2.6% in the 4th quarter. Envestnet Asset Management Inc. now owns 1,898,927 shares of the technology company's stock valued at $86,249,000 after purchasing an additional 48,336 shares in the last quarter. 15.02% of the stock is owned by institutional investors.
Relx Trading Up 0.1 %
Shares of RELX stock traded up $0.04 during mid-day trading on Friday, reaching $49.06. The stock had a trading volume of 1,831,813 shares, compared to its average volume of 725,864. The firm has a market capitalization of $91.05 billion, a PE ratio of 26.37, a price-to-earnings-growth ratio of 2.73 and a beta of 0.84. The stock's 50-day moving average price is $49.29 and its two-hundred day moving average price is $47.87. The company has a current ratio of 0.52, a quick ratio of 0.47 and a debt-to-equity ratio of 1.46. Relx Plc has a 52-week low of $40.25 and a 52-week high of $51.99.
Relx Increases Dividend
The firm also recently declared a semi-annual dividend, which will be paid on Wednesday, June 25th. Investors of record on Friday, May 9th will be issued a dividend of $0.5586 per share. This represents a yield of 1.6%. The ex-dividend date is Friday, May 9th. This is an increase from Relx's previous semi-annual dividend of $0.23. Relx's payout ratio is currently 59.68%.
Analyst Ratings Changes
RELX has been the subject of several recent research reports. Redburn Atlantic started coverage on shares of Relx in a research note on Wednesday, January 8th. They issued a "buy" rating for the company. The Goldman Sachs Group assumed coverage on Relx in a report on Wednesday, March 26th. They issued a "buy" rating on the stock. StockNews.com cut Relx from a "buy" rating to a "hold" rating in a report on Tuesday, March 4th. Finally, Barclays raised Relx from an "equal weight" rating to an "overweight" rating in a research note on Friday, March 14th. One equities research analyst has rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Buy".
Check Out Our Latest Stock Analysis on RELX
About Relx
(
Free Report)
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Featured Articles
Before you consider Relx, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Relx wasn't on the list.
While Relx currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
